Literature DB >> 1524225

Intravenous microdialysis sampling in awake, freely-moving rats.

M Telting-Diaz1, D O Scott, C E Lunte.   

Abstract

Intravenous microdialysis sampling in the awake, freely-moving rat for the determination of free drug concentrations in blood is described. Intravenous microdialysis was performed with a nonmetallic, flexible dialysis probe. The pharmacokinetics of theophylline were determined using both microdialysis sampling and collection of whole blood following an iv dose. There was no difference in the half-life of elimination of theophylline determined by microdialysis, 4.4 +/- 0.4 h, and whole blood sampling, 4.5 +/- 0.7 h. The kinetics of elimination were affected by removing blood samples and by using anesthesia. The half-life of elimination was 4.4 +/- 0.4 h when using simultaneous microdialysis and whole-blood sampling and only 3.0 +/- 0.4 h using microdialysis alone. The half-life of elimination was 17.0 +/- 7.1 h in chloral hydrate anesthesized rats. Microdialysis samples were continuously collected for over 7 h without fluid loss using a single experimental animal. Microdialysis sampling directly assesses the free drug concentration in blood. The extent of theophylline binding to blood proteins was determined in vitro in rat plasma and rat whole blood using both ultrafiltration and microdialysis. Theophylline was (47.3 +/- 1.3)% bound in rat plasma and (52.2 +/- 1.6)% bound in rat whole blood. Microdialysis sampling is a powerful tool for pharmacokinetic studies, providing accurate and precise pharmacokinetic data.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1524225     DOI: 10.1021/ac00031a019

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  21 in total

1.  Microdialysis sampling of the isothiazolone, PD-161374, and its thiol and disulfide metabolites.

Authors:  M Ye; D T Rossi; C E Lunte
Journal:  J Pharm Biomed Anal       Date:  2000-12-15       Impact factor: 3.935

2.  The direct comparison of health and ulcerated stomach tissue: a multiple probe microdialysis sampling approach.

Authors:  Kristin L Woo; Craig E Lunte
Journal:  J Pharm Biomed Anal       Date:  2008-05-20       Impact factor: 3.935

3.  The development of multiple probe microdialysis sampling in the stomach.

Authors:  Kristin L Woo; Craig E Lunte
Journal:  J Pharm Biomed Anal       Date:  2008-04-26       Impact factor: 3.935

Review 4.  Application of microdialysis in pharmacokinetic studies.

Authors:  W F Elmquist; R J Sawchuk
Journal:  Pharm Res       Date:  1997-03       Impact factor: 4.200

Review 5.  Pharmacokinetic and metabolism studies using microdialysis sampling.

Authors:  D K Hansen; M I Davies; S M Lunte; C E Lunte
Journal:  J Pharm Sci       Date:  1999-01       Impact factor: 3.534

6.  In vivo solid-phase microextraction for monitoring intravenous concentrations of drugs and metabolites.

Authors:  Heather L Lord; Xu Zhang; F Marcel Musteata; Dajana Vuckovic; Janusz Pawliszyn
Journal:  Nat Protoc       Date:  2011-06-02       Impact factor: 13.491

7.  Intravenous microdialysis in the mouse and the rat: development and pharmacokinetic application of a new probe.

Authors:  P A Evrard; G Deridder; R K Verbeeck
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

Review 8.  A review of microdialysis coupled to microchip electrophoresis for monitoring biological events.

Authors:  Rachel A Saylor; Susan M Lunte
Journal:  J Chromatogr A       Date:  2015-01-10       Impact factor: 4.759

Review 9.  Analytical and biological methods for probing the blood-brain barrier.

Authors:  Courtney D Kuhnline Sloan; Pradyot Nandi; Thomas H Linz; Jane V Aldrich; Kenneth L Audus; Susan M Lunte
Journal:  Annu Rev Anal Chem (Palo Alto Calif)       Date:  2012       Impact factor: 10.745

10.  LC-MS/MS determination of carbamathione in microdialysis samples from rat brain and plasma.

Authors:  Swetha Kaul; Todd D Williams; Craig E Lunte; Morris D Faiman
Journal:  J Pharm Biomed Anal       Date:  2009-07-30       Impact factor: 3.935

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.